Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (551-560 of 599) with videos related to

Pageof 60
Sort By:
Pain|April 23, 2019
Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neuronsElisabetta Coppi, Federica Cherchi, Irene Fusco, et al.
Journal of Medicinal Chemistry|March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine BioisosteresYoung-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
British Journal of Pharmacology|February 11, 2020
Update of P2Y receptor pharmacology: IUPHAR Review 27Kenneth A Jacobson, Esmerilda G Delicado, Christian Gachet, et al.
Journal of Medicinal Chemistry|August 14, 2020
Exploration of Alternative Scaffolds for P2Y<sub>14</sub> Receptor Antagonists Containing a Biaryl CoreYoung-Hwan Jung, Jinha Yu, Zhiwei Wen, et al.
Journal of Medicinal Chemistry|July 3, 2024
Lipid Trolling to Optimize A<sub>3</sub> Adenosine Receptor-Positive Allosteric Modulators (PAMs)Balaram Pradhan, Matteo Pavan, Courtney L Fisher, et al.
Biochemical Pharmacology|April 24, 2004
Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moietyZhan-Guo Gao, Lak Shin Jeong, Hyung Ryong Moon, et al.
Journal of Medicinal Chemistry|January 26, 2022
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 InhibitorsMirko Scortichini, Riham Mohammed Idris, Susanne Moschütz, et al.
Drug Development Research|August 28, 2012
Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor AntagonistsYong-Chul Kim, Emidio Camaioni, Airat U Ziganshin, et al.
Journal of Medicinal Chemistry|October 26, 2018
Preclinical Evaluation of the First Adenosine A<sub>1</sub> Receptor Partial Agonist Radioligand for Positron Emission Tomography ImagingMin Guo, Zhan-Guo Gao, Ryan Tyler, et al.
Pageof 60

Showing results (551-560 of 599) with videos related to

Sort By:
Pageof 60
Pain|April 23, 2019
Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neuronsElisabetta Coppi, Federica Cherchi, Irene Fusco, et al.
Journal of Medicinal Chemistry|March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine BioisosteresYoung-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
British Journal of Pharmacology|February 11, 2020
Update of P2Y receptor pharmacology: IUPHAR Review 27Kenneth A Jacobson, Esmerilda G Delicado, Christian Gachet, et al.
Journal of Medicinal Chemistry|August 14, 2020
Exploration of Alternative Scaffolds for P2Y<sub>14</sub> Receptor Antagonists Containing a Biaryl CoreYoung-Hwan Jung, Jinha Yu, Zhiwei Wen, et al.
Journal of Medicinal Chemistry|July 3, 2024
Lipid Trolling to Optimize A<sub>3</sub> Adenosine Receptor-Positive Allosteric Modulators (PAMs)Balaram Pradhan, Matteo Pavan, Courtney L Fisher, et al.
Biochemical Pharmacology|April 24, 2004
Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moietyZhan-Guo Gao, Lak Shin Jeong, Hyung Ryong Moon, et al.
Journal of Medicinal Chemistry|January 26, 2022
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 InhibitorsMirko Scortichini, Riham Mohammed Idris, Susanne Moschütz, et al.
Drug Development Research|August 28, 2012
Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor AntagonistsYong-Chul Kim, Emidio Camaioni, Airat U Ziganshin, et al.
Journal of Medicinal Chemistry|October 26, 2018
Preclinical Evaluation of the First Adenosine A<sub>1</sub> Receptor Partial Agonist Radioligand for Positron Emission Tomography ImagingMin Guo, Zhan-Guo Gao, Ryan Tyler, et al.
Pageof 60